Search Results (84)

Widespread antibiotic residues are accumulating in the environment, potentially causing adverse effects for humans, animals, and the ecosystem, including an increase in antibiotic-resistant bacteria, resulting in worldwide concern. There are various commonly used physical, chemical, and biological treatments for the degradation of antibiotics. However, the elimination of toxic end products generated by physicochemical methods and the need for industrial applications pose significant challenges. Hence, environmentally sustainable, green, and readily available approaches for the transformation and degradation of these antibiotic compounds are being sought. Herein, we review the impact of sustainable fungal laccase-based bioremediation strategies. Fungal laccase enzyme is considered one of the most active enzymes for biotransformation and biodegradation of antibiotic residue in vitro. For industrial applications, the low laccase yields in natural and genetically modified hosts may constitute a bottleneck. Methods to screen for high-laccase-producing sources, optimizing cultivation conditions, and identifying key genes and metabolites involved in extracellular laccase activity are reviewed. These include advanced transcriptomics, proteomics, and metagenomics technologies, as well as diverse laccase-immobilization technologies with different inert carrier/support materials improving enzyme performance whilst shifting from experimental assays to in situ monitoring of residual toxicity. Still, more basic and applied research on laccase-mediated bioremediation of pharmaceuticals, especially antibiotics that are recalcitrant and prevalent, is needed. Full article

Biofilms are structured communities of microorganisms encased in a self-produced extracellular matrix, and they represent one of the most widespread forms of microbial life on Earth. Their presence poses serious challenges in both environmental and clinical settings. In natural and industrial systems, biofilms contribute to water contamination, pipeline corrosion, and biofouling. Clinically, biofilm-associated infections are responsible for approximately 80% of all microbial infections, including endocarditis, osteomyelitis, cystic fibrosis, and chronic sinusitis. A particularly critical concern is their colonization of medical devices, where biofilms can lead to chronic infections, implant failure, and increased mortality. Implantable devices, such as orthopedic implants, cardiac pacemakers, cochlear implants, urinary catheters, and hernia meshes, are highly susceptible to microbial attachment and biofilm development. These infections are often recalcitrant to conventional antibiotics and frequently necessitate surgical revision. In the United States, over 500,000 biofilm-related implant infections occur annually, with prosthetic joint infections alone projected to incur revision surgery costs exceeding USD 500 million per year—a figure expected to rise to USD 1.62 billion by 2030. To address these challenges, surface modification of medical devices has emerged as a promising strategy to prevent bacterial adhesion and biofilm formation. This review focuses on recent advances in chemical surface functionalization using non-antibiotic agents, such as enzymes, chelating agents, quorum sensing quenching factors, biosurfactants, oxidizing compounds and nanoparticles, designed to enhance antifouling and mature biofilm eradication properties. These approaches aim not only to prevent device-associated infections but also to reduce dependence on antibiotics and mitigate the development of antimicrobial resistance. Full article

Pseudomonas aeruginosa biofilm formation is critical to antibiotic resistance and persistence. Targeting cyclic di-GMP (c-di-GMP) signaling, a master biofilm formation and virulence regulator, presents a promising strategy to combat resistant bacterial infections. Myricetin, a natural polyphenolic flavonoid with documented antimicrobial and anti-biofilm activities, may enhance antibiotic efficacy against Pseudomonas aeruginosa. This study evaluated the synergistic effects of myricetin combined with azithromycin, ciprofloxacin, or cefdinir against both standard and drug-resistant Pseudomonas aeruginosa strains. Antibacterial activity, biofilm disruption, and motility inhibition were experimentally assessed, while molecular dynamic (MD) simulations elucidated myricetin’s molecular mechanism of action. Our results suggested that myricetin synergistically potentiated all three antibiotics, reducing c-di-GMP synthesis by 28% (azithromycin), 57% (ciprofloxacin), and 30% (cefdinir). It enhanced bactericidal effects, suppressed biofilm formation, and impaired swimming, swarming, and twitching motility. Computational analyses revealed that myricetin binds allosterically to FimX very well, a key regulator in the c-di-GMP signaling pathway. Hence, myricetin may act as a c-di-GMP inhibitor, reversing biofilm-mediated resistance in Pseudomonas aeruginosa and augmenting antibiotic efficacy. This integrated experimental and computational approach provides a framework for developing anti-virulence and antibiotic combination therapies against recalcitrant Gram-negative pathogens. Full article

Most large-scale crude oil spills occur in marine environments. We screened easily propagable/maintainable halophiles to develop agents for the bioremediation of marine spills. A bacterial strain isolated from a polluted region of the Great Salt Lake was characterized and tested for its ability to degrade crude oil. The strain (Salinivibrio costicola) is motile, catalase- and lipase-positive, a facultative anaerobe, and an obligate halophile. Its growth optimum and tolerance ranges are: NaCl (5%, 1.25–10%), pH (8, 6–10), and temperature (22 °C, 4–45 °C). Its genome (3,166,267 bp) consists of two circular chromosomes and a plasmid, containing 3197 genes, including some genes potentially relevant to hydrocarbon metabolism. The strain forms a biofilm but is considered nonpathogenic and is sensitive to some common antibiotics. Lytic bacteriophages infecting the strain are rare in the water samples we tested. The strain survived on desiccated agar media at room temperature for a year, grew optimally in complex media containing 0.1–1% crude oil, but failed to reduce total recoverable petroleum hydrocarbons from crude oil. Thus, a recalcitrant halophile may endure crude oil without mineralizing. Due to some of their advantageous attributes, such strains can be considered for genetic manipulation to develop improved agents for bioremediation. Full article

Industrial organic wastewater, with its complex composition, high biological toxicity, and recalcitrance, has become a major challenge in water pollution control. This is especially true for antibiotic-containing wastewater, such as ofloxacin wastewater, for which there is an urgent need to develop effective treatment technologies. Conventional treatment processes are insufficiently efficient, while individual advanced oxidation processes (AOPs) have drawbacks such as poor oxidation selectivity and catalyst deactivation. To address these issues, researchers have explored the coupling of different AOPs and found that such combinations can enhance the oxidation performance, achieve complementary advantages, reduce the equipment costs, and offer great development potential. An experiment was conducted to evaluate the performance of an Ozone-Electro-Fenton coupled process in treating ofloxacin industrial wastewater. The results demonstrated that under the same conditions, after four hours of treatment, the coupled process achieved a 70% reduction in the UV absorption peak of the wastewater, compared to less than 20% for individual processes, indicating a significant synergistic effect. Further optimization of the ozone aeration structure revealed that with a hole size of 0.5 mm, single-layer aeration holes, and six holes, the COD removal rate reached 96% after six hours, the ozone utilization improved to 85%, and the gas holdup stabilized at 4.6%. Under these conditions, the mixture of ozone and air bubbles formed mixed bubbles. Influenced by the electric field and electrode plate wall effects, the bubble residence time was prolonged. The bubble size was approximately 2.8 mm, the gas flow horizontal velocity was about 18.5 m/s, and after a horizontal displacement of 0.17 mm in the wastewater, the lateral velocity became zero. The ratio of the distance between the bubble center and the wall to the equivalent bubble diameter was approximately 3.45. The bubbles were subject to a strong wall effect, which extended their residence time. This not only facilitated the removal of small bubbles from the electrode plates but also enhanced the ion diffusion near the plates, thereby boosting pollutant degradation. This study shows that the Ozone-Electro-Fenton coupled process is highly effective in degrading ofloxacin industrial wastewater, offering an innovative solution for treating other antibiotic-containing wastewater. Future research will focus on further optimizing the process, improving its adaptability to complex matrix wastewater, and validating it at the pilot scale to promote its engineering application. Full article

Antibiotic pollution, particularly via tetracycline (TC), poses significant environmental risks due to its recalcitrance and potential to induce antibiotic resistance. This study employed density functional theory (DFT) and transition state theory (TST) to investigate TC degradation by hydroxyl radicals (·OH), focusing on hydrogen atom transfer (HAT) and radical adduct formation (RAF) pathways. Geometry optimizations and vibrational analysis validated stationary points, while intrinsic reaction coordinate (IRC) calculations confirmed transition states. Key findings reveal that RAF pathways exhibit lower activation barriers (1.23–30.33 kJ/mol) and greater exothermicity (−164.42 kJ/mol) compared to HAT pathways (3.51–42.04 kJ/mol, −109.58 kJ/mol), making them kinetically and thermodynamically dominant. Frontier molecular orbital (FMO) analysis links HAT to TC’s HOMO (π-orbital character on aromatic rings) and RAF to its LUMO (electrophilic sites). Rate constants calculated at 298 K (TST with Wigner correction) confirm RAF’s kinetic superiority (up to 7.0 × 10¹¹ s⁻¹), surpassing HAT’s fastest pathway (6.2 × 10¹¹ s⁻¹). These insights advance the understanding of TC degradation mechanisms and help with the design of efficient photocatalytic oxidation processes for antibiotic removal. Full article

Infectious diseases, the second leading cause of death worldwide, have traditionally been treated with antimicrobials. However, the emergence of drug-resistant microorganisms has driven the need for alternative therapies. This study aimed to assess the antibacterial efficacy of Capparis spinosa crude extracts and five essential oils (EOs) derived from Salvia officinalis, Eucalyptus globulus, Micromeria barbata, Origanum vulgare, and Juniperus excelsa. The EOs were extracted using hydro-distillation, and C. spinosa extracts were obtained using ethanol and acetone solvents. Microdilution assays revealed that O. vulgare EO exhibited the strongest activity against Listeria monocytogenes, Escherichia coli, Salmonella spp., and Brucella melitensis, while C. spinosa demonstrated significant antibacterial effects against L. monocytogenes and notable inhibition of Pseudomonas aeruginosa. The combination of EOs with antibiotics, including M. barbata, J. excelsa, S. officinalis, and E. globulus, enhanced the efficacy of the antibiotics against recalcitrant bacterial strains. The synergistic effects were evaluated through Fractional Inhibitory Concentration Index (FICI) analysis. These findings confirm that the antibacterial efficacy observed in the tested EOs, especially when used in synergy with antibiotics, offers a promising therapeutic strategy to combat antimicrobial resistance. Full article

The emergence of multi-drug resistance (MDR) poses a huge risk to public health globally. Yet these recalcitrant pathogens continue to rise in incidence rate with resistance rates significantly outpacing the speed of antibiotic development. This therefore presents related health issues such as untreatable nosocomial infections arising from organ transplants and surgeries, as well as community-acquired infections that are related to people with compromised immunity, e.g., diabetic and HIV patients, etc. There is a global effort to fight MRD pathogens spearheaded by the World Health Organization, thus calling for research into novel antimicrobial agents to fight multiple drug resistance. Previously, our laboratory demonstrated that Cannabidiol (CBD) is an effective antimicrobial against Salmonella typhimurium (S. typhimurium). However, we observed resistance development over time. To understand the mechanisms S. typhimurium uses to develop resistance to CBD, we studied the abundance of bacteria lipopolysaccharide (LPS) and membrane sterols of both CBD-susceptible and CBD-resistant S. typhimurium strains. Using real-time quantitative polymerase chain reaction (rt qPCR), we also analyzed the expression of selected genes known for aiding resistance development in S. typhimurium. We found a significantly higher expression of blaTEM (over 150 mRNA expression) representing over 55% of all the genes considered in the study, fimA (over 12 mRNA expression), fimZ (over 55 mRNA expression), and integron 2 (over 1.5 mRNA expression) in the CBD-resistant bacteria, and these were also accompanied by a shift in abundance in cell surface molecules such as LPS at 1.76 nm, ergosterols at 1.03 nm, oleic acid at 0.10 nm and MPPSE at 2.25nm. For the first time, we demonstrated that CBD-resistance development in S. typhimurium might be caused by several structural and genetic factors. These structural factors demonstrated here include LPS and cell membrane sterols, which showed significant differences in abundances on the bacterial cell surfaces between the CBD-resistant and CBD-susceptible strains of S. typhimurium. Specific key genetic elements implicated for the resistance development investigated included fimA, fimZ, int2, ompC, blaTEM, DNA recombinase (STM0716), leucine-responsive transcriptional regulator (lrp/STM0959), and the spy gene of S. typhimurium. In this study, we revealed that blaTEM might be the highest contributor to CBD-resistance, indicating the potential gene to target in developing agents against CBD-resistant S. typhimurium strains. Full article

The sustainability of aquaculture tailwater plays a key role in the aquaculture industry. Photocatalytic degradation of recalcitrant antibiotics in aquaculture tailwater has emerged as a significant research focus, with gCN-based photocatalysis offering a promising approach. To address the issue of inefficient degradation associated with gCN, melamine was modified using NaCl solution, resulting in the synthesis of NaMe-x with distinctive microstructure through molten salt assistance. The ability of NaMe-x to degrade tetracycline hydrochloride (TC-HCl) was examined, including an analysis of its degradation pathway, intermediate products, mechanism, and toxicity of the by-products. The results demonstrated that NaCl-based precursor modification markedly enhanced the degradation capacity of gCN for TC-HCl, achieving a maximum degradation rate of 0.02214 min⁻¹, which is 2.1 times higher than that of unmodified gCN. LC-MS analysis revealed intermediates at various degradation stages, and two potential pathways for TC-HCl degradation in the presence of NaMe-1 were identified. In this process, ·O₂⁻ and ·OH are the reactive radicals that play a dominant role, and their degradation mechanism is thus proposed. It was confirmed by toxicity experiments that the products after the degradation of TC-HCl by NaMe-1 were not significantly toxic to Chlorella vulgaris (p ˃ 0.05). However, it had a significant effect on Vibrio fischeri (p < 0.01). These findings suggest that the synthesis of NaMe-x via melamine precursor modification substantially improves the degradation performance of gCN and enhances the sustainability of aquaculture tailwater. Full article

Biofilms, composed of structured communities of bacteria embedded in a self-produced extracellular matrix, pose a significant challenge due to their heightened resistance to antibiotics and immune responses. This review highlights the mechanisms underpinning antibiotic resistance within bacterial biofilms, elucidating the adaptive strategies employed by microorganisms to withstand conventional antimicrobial agents. This encompasses the role of the extracellular matrix, altered gene expression, and the formation of persister cells, contributing to the recalcitrance of biofilms to eradication. A comprehensive understanding of these resistance mechanisms provides a for exploring innovative therapeutic interventions. This study explores promising avenues for future research, emphasizing the necessity of uncovering the specific genetic and phenotypic adaptations occurring within biofilms. The identification of vulnerabilities in biofilm architecture and the elucidation of key biofilm-specific targets emerge as crucial focal points for the development of targeted therapeutic strategies. In addressing the limitations of traditional antibiotics, this review discusses innovative therapeutic approaches. Nanomaterials with inherent antimicrobial properties, quorum-sensing inhibitors disrupting bacterial communication, and bacteriophages as biofilm-specific viral agents are highlighted as potential alternatives. The exploration of combination therapies, involving antimicrobial agents, biofilm-disrupting enzymes, and immunomodulators, is emphasized to enhance the efficacy of existing treatments and overcome biofilm resilience. Full article

Coriolopsis gallica (Cga) is a white-rot fungus renowned for its ability to secrete ligninolytic enzymes that are capable of oxidizing phenolic compounds. This study aimed to investigate the biochemical characteristics of a dye-decolorizing peroxidase named CgaDyP1 and test its ability to biotransform antibiotics. CgaDyP1 was cloned and heterologously expressed in Escherichia coli. We fully characterized the biochemical properties of CgaDyP1 and evaluated its dye-decolorizing potential to confirm that it belongs to the DyP class of enzymes. We also tested its fluoroquinolone antibiotic biotransformation potential for possible biotechnological applications. Alignment of the primary amino acid sequence with DyP homolog sequences showed that CgaDyP1 has high similarity with other fungal DyPs. The recombinant CgaDyP1 exhibited activity on substrates such as ABTS and 2,6-dimethoxyphenol (DMP) with optimal performance at a pH of 3, although activity at pH 2.5, pH 4, and pH5 diminished over time. Thermostability tests indicated that the enzyme remains stable at temperatures between 30 °C and 50 °C and retains 70% of its initial activity after 180 min at 50 °C. Tests on the effect of hydrogen peroxide on CgaDyP1 activity found peak activity at 0.25 mM H₂O₂. CgaDyP1 decolorized five industrial dyes, and kinetics data confirmed that it belongs to the DyP class of enzymes. CgaDyP1 was shown to biotransform some of the 7 recalcitrant fluoroquinolone antibiotics tested here, including levofloxacin, moxifloxacin, and norfloxacin, and thus holds potential for biotechnological applications. Full article

Recalcitrant frontal sinusitis in patients with chronic rhinosinusitis and nasal polyps (CRSwNP) has a negative impact on their quality of life due to frontal pain and a high risk of sinus occlusion, thus necessitating antibiotics, systemic corticosteroids, and multiple surgeries. The aim of this study was to assess the efficacy of dupilumab in reducing frontal pain and the need for rescue treatments for recalcitrant frontal sinusitis in patients with CRSwNP. We enrolled a cohort of 10 patients with severe uncontrolled CRSwNP and concomitant recurrent frontal sinusitis associated with severe facial pain measured by MIDAS score who were treated with dupilumab 300 mg every 2 weeks and followed for at least 12 months. The mean MIDAS score decreased from 45.6 ± 10.7 at baseline to 1.3 ± 2.3 at 6 months (p < 0.05). VAS craniofacial pain decreased from 7.3 ± 1.6 at baseline to 1.2 ± 1.5 at 6 months (p < 0.05). No patient needed oral corticosteroids during treatment with dupilumab (p < 0.05), and the use of analgesics decreased from 9.6 ± 3.1 NSAID pills/week in the last 2 months at baseline to 0.6 ± 1.3 at 1 year of follow-up (p < 0.05). Our results demonstrated that use of subcutaneous dupilumab can improve symptom control, including recurrent severe cranio-facial pain, and reduce the need for rescue medical treatments (systemic steroids and NSAID) in patients with severe uncontrolled CRSwNP and concomitant recurrent frontal sinusitis. Full article

The use of heterogeneous photocatalysis has garnered significant attention, mainly due to its remarkable efficacy in degrading recalcitrant compounds. The main objective of this research was to investigate this process applied to pharmaceutical treatment. For that, an analysis of a Final Bibliographic Portfolio (FBP), using the systematic review of the PRISMA and the ProKnow-C method, and a meta-analysis study in a historical series from 2010 to 2020, were performed for scientific works published in indexed journals from the Scopus and Web of Science databases and fully available in English. The works were filtered after a careful reading of the titles, followed by the exclusion of repeated documents and those that were not aligned with the research from 3498 articles, 40 of which were chosen to compose the FBP that addressed the classes of antibiotics, antihypertensives, analgesics, and anti-inflammatory drugs after scientific recognition and exclusion due to not fitting into one of the four FBP structured stages: (1) identification, (2) triage, (3) eligibility, and (4) inclusion. The following gaps were highlighted: (i) a limited number of studies working with interactions of the interfering variables; (ii) a large number of experiments not considering the natural constituents of wastewater; (iii) the use of drug concentrations high above the values found in aquatic matrices; (iv) little applicability of the process at the real scale. In this meta-analysis study, operational parameter optimization was fundamental to guarantee degradation efficiencies above 80% with a variety of pharmaceutical pollutants, the main representatives studied of which were tetracycline, nimesulide, diclofenac, ibuprofen, and atenolol. However, there is still a need to determine the best conditions for this technique when using real effluents, which have the utmost importance for the process on a large scale. Full article

Persisters are antibiotic-tolerant bacteria, playing a role in the recalcitrance and relapse of many bacterial infections, including P. aeruginosa pulmonary infections in Cystic Fibrosis (CF) patients. Among novel antimicrobial strategies, the use of probiotics and their products is emerging as a particularly promising approach. The aim of this study was to evaluate the anti-persisters activity of culture filtrate supernatants of Lacticaseibacillus rhamnosus (LRM-CFS) against P. aeruginosa in artificial sputum medium (ASM), which resembles the CF lung environment. Planktonic persisters of two clinical strains of P. aeruginosa (PaCF1 and PaCF4) were obtained following two different procedures: (i) exposing stationary-phase cultures to cyanide m-chlorophenylhydrazone (CCCP) in LB medium; (ii) incubating stationary-phase cultures with high doses of tobramycin (128-fold MIC) in ASM. In addition, persisters from biofilm were obtained by exposing 48 h old biofilm of P. aeruginosa to 128 x MIC of ciprofloxacin. LRM-CFS at dilutions of 1:6 and 1:4 resulted in being bactericidal in ASM against both PaCF1 and PaCF4 persisters obtained after CCCP or tobramycin treatment. Moreover, LRM-CFS at dilution 1:4 caused a reduction of antibiotic-tolerant bacteria in the biofilm of both P. aeruginosa strains. Overall, LRM-CFS represents a promising adjuvant therapeutic strategy against P. aeruginosa recalcitrant infections in CF patients. Full article

The Gram-negative ESKAPE bacterium Pseudomonas aeruginosa has become a pathogen of serious concern due its extensive multi-drug resistance (MDR) profile, widespread incidences of hospital-acquired infections throughout the United States, and high occurrence in wound infections suffered by warfighters serving abroad. Bacteriophage (phage) therapy has received renewed attention as an alternative therapeutic option against recalcitrant bacterial infections, both as multi-phage cocktails and in combination with antibiotics as synergistic pairings. Environmental screening and phage enrichment has yielded three lytic viruses capable of infecting the MDR P. aeruginosa strain PAO1. Co-administration of each phage with the carbapenem antibiotics ertapenem, imipenem, and meropenem generated enhanced overall killing of bacteria beyond either phage or drug treatments alone. A combination cocktail of all three phages was completely inhibitory to growth, even without antibiotics. The same 3× phage cocktail also disrupted PAO1 biofilms, reducing biomass by over 75% compared to untreated biofilms. Further, the phage cocktail demonstrated broad efficacy as well, capable of infecting 33 out of 100 diverse clinical isolate strains of P. aeruginosa. Together, these results indicate a promising approach for designing layered medical countermeasures to potentiate antibiotic activity and possibly overcome resistance against recalcitrant, MDR bacteria such as P. aeruginosa. Combination therapy, either by synergistic phage-antibiotic pairings, or by phage cocktails, presents a means of controlling mutations that can allow for bacteria to gain a competitive edge. Full article